Loss of tumor target antigen expression and conversion to a more immunosuppressive state with increased infiltration of Tregs and higher expression of immunosuppressive molecules has also been observed in a phase I study of EGFR-vIII CAR T cells in participants with recurrent glioblastoma76. The gene discussed is EGFR; the disease is neoplasm.